Literature DB >> 15188500

Effects of lactose as an inducer on expression of Helicobacter pylori rUreB and rHpaA, and Escherichia coli rLTKA63 and rLTB.

Jie Yan1, Shou-Feng Zhao, Ya-Fei Mao, Yi-Hui Luo.   

Abstract

AIM: To demonstrate the effect of lactose as an inducer on expression of the recombinant proteins encoded by Helicobacter pylori ureB and hpaA, and Escherichia coli LTB and LTKA63 genes and to determine the optimal expression parameters.
METHODS: By using SDS-PAGE and BIO-RAD gel image analysis system, the outputs of the target recombinant proteins expressed by pET32a-ureB-E.coliBL21, pET32a-hpaA-E.coliBL21, pET32a-LTKA63-E.coliBL21 and pET32a-LTB-E.coliBL21 were measured when using lactose as inducer at different dosages, original bacterial concentrations, various inducing temperatures and times. The results of the target protein expression induced by lactose were compared to those by isopropyl-beta-D-thiogalactoside (IPTG). The proteins were expressed in E.coli.
RESULTS: Lactose showed higher efficiency of inducing the expression of rHpaA, rUreB, rLTB and rLTKA63 than IPTG. The expression outputs of the target recombinant proteins induced at 37 degrees were remarkably higher than those at 28 degrees. Other optimal expression parameters for the original bacterial concentrations, dosages of lactose and inducing time were 0.8, 50 g/L and 4 h for rHpaA; 0.8, 100 g/L and 4 h for rLTKA63; 1.2, 100 g/L and 5 h for both rUreB and rLTB, respectively.
CONCLUSION: Lactose, a sugar with non-toxicity and low cost, is able to induce the recombinant genes to express the target proteins with higher efficiency than IPTG. The results in this study establish a beneficial foundation for industrial production of H pylori genetic engineering vaccine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15188500      PMCID: PMC4572263          DOI: 10.3748/wjg.v10.i12.1755

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

1.  Clinicopathological analysis of patients with gastric cancer in 1200 cases.

Authors:  W X Niu; X Y Qin; H Liu; C P Wang
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  B-cell monoclonality in Helicobacter pylori-associated chronic atrophic gastritis.

Authors:  T Hiyama; K Haruma; Y Kitadai; M Miyamoto; S Tanaka; M Yoshihara; K Sumii; F Shimamoto; G Kajiyama
Journal:  Virchows Arch       Date:  2001-03       Impact factor: 4.064

3.  Helicobacter pylori membrane protein 1: a new carcinogenic factor of Helicobacter pylori.

Authors:  M Suganuma; M Kurusu; S Okabe; N Sueoka; M Yoshida; Y Wakatsuki; H Fujiki
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

Review 4.  A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates.

Authors:  M H Houben; D van de Beek; E F Hensen; A J de Craen; E A Rauws; G N Tytgat
Journal:  Aliment Pharmacol Ther       Date:  1999-08       Impact factor: 8.171

5.  [Construction of prokaryotic expression system of ureB gene from a clinical isolate of Helicobacter pylori and identification of immunogenicity of the fusion protein].

Authors:  Zhe Chen; Jie Yan; Ya-Fei Mao
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2003-02

6.  [Cloning, expression and identification of hpaA gene from a clinical isolate of Helicobacter pylori].

Authors:  Ya-Fei Mao; Jie Yan; Li-Wei Li
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2003-02

Review 7.  New generation of mucosal adjuvants for the induction of protective immunity.

Authors:  Yoshikazu Yuki; Hiroshi Kiyono
Journal:  Rev Med Virol       Date:  2003 Sep-Oct       Impact factor: 6.989

8.  Eradication of chronic Helicobacter pylori infection by therapeutic vaccination.

Authors:  J E Crabtree
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

9.  Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice.

Authors:  I Corthésy-Theulaz; N Porta; M Glauser; E Saraga; A C Vaney; R Haas; J P Kraehenbuhl; A L Blum; P Michetti
Journal:  Gastroenterology       Date:  1995-07       Impact factor: 22.682

10.  [Cloning, expression and identification of Escherichia coli LTB gene and Vibrio cholerae CTB gene].

Authors:  Xiao-Ping Xia; Jie Yan; Shou-Feng Zhao
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2003-02
View more
  3 in total

1.  Pilot-scale production of a highly thermostable α-amylase enzyme from Thermotoga petrophila cloned into E. coli and its application as a desizer in textile industry.

Authors:  Asma Zafar; Muhammad Nauman Aftab; Irfana Iqbal; Zia Ud Din; Mushtaq Ahmad Saleem
Journal:  RSC Adv       Date:  2019-01-08       Impact factor: 4.036

2.  Intermittent induction of LEA peptide by lactose enhances the expression of insecticidal proteins in Bacillus thuringiensis.

Authors:  Mahmuda Akthar; Tomoko Shimokawa; Yinghan Wu; Taichi Arita; Kazuhiro Mizuta; Yuria Isono; Minoru Maeda; Shinya Ikeno
Journal:  FEBS Open Bio       Date:  2022-06-15       Impact factor: 2.792

3.  Secretory expression and purification of recombinant Escherichia coli heat-labile enterotoxin B subunit and its applications on intranasal vaccination of hantavirus.

Authors:  Shouchun Cao; Ying Zhang; Feng Liu; Qin Wang; Quanfu Zhang; Qinzhi Liu; Chuan Li; Mifang Liang; Dexin Li
Journal:  Mol Biotechnol       Date:  2008-12-17       Impact factor: 2.695

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.